Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...

Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.

The FDA has required the manufacturers of the RSV Vaccines Abrysvo and Arexvy to add a new warning to their labels about the ...

North America severe asthma market is set for growth, driven by high asthma prevalence, increased awareness, and advanced treatment options for severe cases. Ankush Nikam Future Market Insights, Inc.

Saisei Ventures, a leading investment firm focused on advancing Japanese biotechnology and therapeutic innovations, announced today that Dr. Sven Kili has been appointed partner at the firm. Dr. Kili ...

Read about vaccine sales, Akums and more in the latest Market Talks covering Health Care.

A novel combination for relapsed/refractory multiple myeloma produced responses in about 80% of a heavily treated population, ...

This latest investment, which brings OXcan’s total funding to date to $16.7 million, will be used to develop and globally ...

Barré for every million doses given.

Shares of GSK PLC GSK inched down 0.77% to £13.50 Thursday, on what proved to be an all-around positive trading session for ...

The move will place students in good stead to take up skilled roles in biopharma manufacturing. Read more at straitstimes.com ...